Filter
940
Filtered Results: 940
Text search:
Ministry
of
Health
(The
Republic
of
Uganda)
Featured
Recommendations
89
New Publications
298
Language
Document type
No document type
573
Studies & Reports
196
Guidelines
76
Strategic & Response Plan
41
Manuals
29
Situation Updates
11
Fact sheets
5
Training Material
4
Infographics
3
Brochures
1
App
1
Countries / Regions
Uganda
145
Kenya
47
Global
46
Rwanda
39
Africa
37
Congo, Democratic Republic of
36
South Sudan
31
Ethiopia
28
Liberia
24
Sierra Leone
22
Tanzania
20
Zambia
19
East and Southern Africa
14
Nigeria
13
Malawi
12
Guinea
11
South Africa
10
Ghana
8
Namibia
8
West and Central Africa
8
Cameroon
7
Mozambique
7
Zimbabwe
6
Central African Republic
6
Latin America and the Carribbean
6
India
5
Bangladesh
5
Burundi
5
Western and Central Europe
5
Senegal
4
Somalia
4
Syria
4
Sudan
4
Botswana
4
Nepal
3
Jordan
3
Afghanistan
3
Lebanon
3
Colombia
3
Angola
3
Lesotho
3
Burkina Faso
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Togo
2
Philippines
2
Pakistan
2
Iraq
2
Germany
2
Chad
2
Cambodia
2
Indonesia
2
Peru
2
Eswatini/ Swaziland
2
Brazil
2
Madagascar
2
Myanmar / Burma
2
Yemen
2
Eastern Europe and Central Asia
2
Southern Africa
2
Iran
2
Vietnam
2
Morocco
1
Saudi Arabia
1
Haiti
1
Egypt
1
Thailand
1
Papua New Guinea
1
Benin
1
Vanuatu
1
Argentina
1
Ukraine
1
Ecuador
1
Bolivia
1
Greece
1
Chile
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Solomon Islands
1
Venezuela
1
North Korea
1
Albania
1
Djibouti
1
Laos
1
Russia
1
Georgia
1
North America
1
Gabon
1
Mauritius
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
351
Clinical Guidelines
60
Women & Child Health
57
Public Health
53
Key Resources
44
Capacity Building
11
Pharmacy & Technologies
8
Annual Report MEDBOX
1
Toolboxes
HIV
115
Ebola
63
COVID-19
57
Mental Health
51
TB
49
Rapid Response
42
Disability
34
Conflict
27
Planetary Health
27
NTDs
27
Caregiver
26
AMR
22
Refugee
17
Global Health Education
16
Pharmacy
12
Zika
10
NCDs
8
Health Financing Toolbox
6
Cholera
4
Natural Hazards
4
Polio
2
South Sudan
2
Specific Hazards
2
Social Ethics
2
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs ... NCDs are significant and are due principally to their impact on the non-health sector (reduced workforce and productivity). In this study, it is estimated that NCDs cost Ethiopia at least 31.3 billion birr (US$ 1.1 billion) per year, equivalent to 1.8% of the gross domestic product (GDP). Less than 15% of the costs are for health care.
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis ... pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, especially when further testing of sputum smear-negative specimens is necessary.
A study conducted by the World Health Organisation Regional Office for Africa. The COVID-19 pandemic has had a significant impact on older persons ...
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-...-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infectious diseases in the ministries of health (especially but not limited to endemic countries), nongovernmental organizations, clinicians, pharmaceutical companies, donors and affected persons
January 2020 to December 2021
A step towards implementation of the Convention on the Rights of Persons with Disabilities (CRPD...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for ... Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
For humanitarian organisations to respond effectively to complex crises, they require access to up-to-date evidence-based guidance. The COVID-19 crisis has highlighted the importance ... updating global guidance to context-specific and evolving needs in humanitarian settings. Our study aimed to understand the use of evidence-based guidance in humanitarian responses during COVID-19. Primary data collected during the rapidly evolving pandemic sheds new light on evidence-use processes in humanitarian response.
The WHO Toolkit for the care and support of people affected by complications associated with Zika virus has been developed to serve as a model gui...
This report reviews the current situation in relation to national capacity to address NCDs and the progress made at country level over the past dec...
The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compou...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthe...
Circumcision – consultative review of additional information, 12 August 2016
21 September 2016
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs ... the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there is a category of medicines that faces a unique challenge in terms of availability. These are the medicines governed by the international conventions on narcotic and psychotropic substances. “Controlled medicines” is the common definition for pharmaceuticals whose active principles are listed under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol, such as morphine and methadone; the 1971 United Nations Convention on Psychotropic Substances, such as diazepam and buprenorphine; and the 1988 United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, such as ergometrine and ephedrine. The conventions list substances in “Schedules” according to their different levels of potential for abuse and harm, and the commensurate severity of control measures to be applied by countries.
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth ... the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to address the emergency.
MAAP reviewed 819,584 AMR records from 2016-2019, from 205 laboratories across Burkina Faso, Cameroon, Eswatini, Gabon, Ghana, Kenya, Malawi, Nigeria, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, and Zimbabwe. MAAP also reviewed data from 327 hospital and community pharmacies and 16 national-level AMC datasets.
